Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

The Kaiser Permanente shoulder arthroplasty registry: results from 6,336 primary shoulder arthroplasties.

Dillon MT, Ake CF, Burke MF, Singh A, Yian EH, Paxton EW, Navarro RA.

Acta Orthop. 2015 Jun;86(3):286-92. doi: 10.3109/17453674.2015.1024565. Epub 2015 Mar 2.

2.

Injury pathology at the time of anterior cruciate ligament reconstruction associations with self-assessment of knee function.

Inacio MC, Chen Y, Maletis GB, Ake CF, Fithian DC, Granan LP.

Clin J Sport Med. 2014 Nov;24(6):461-7. doi: 10.1097/JSM.0000000000000077.

PMID:
24569492
3.

Sex and risk of hip implant failure: assessing total hip arthroplasty outcomes in the United States.

Inacio MC, Ake CF, Paxton EW, Khatod M, Wang C, Gross TP, Kaczmarek RG, Marinac-Dabic D, Sedrakyan A.

JAMA Intern Med. 2013 Mar 25;173(6):435-41. doi: 10.1001/jamainternmed.2013.3271.

PMID:
23420484
4.

Risk of revision for fixed versus mobile-bearing primary total knee replacements.

Namba RS, Inacio MC, Paxton EW, Ake CF, Wang C, Gross TP, Marinac-Dabic D, Sedrakyan A.

J Bone Joint Surg Am. 2012 Nov 7;94(21):1929-35. doi: 10.2106/JBJS.K.01363.

PMID:
23138235
5.

Gastrointestinal lymphomas: Morphology, immunophenotype and molecular features.

Bautista-Quach MA, Ake CD, Chen M, Wang J.

J Gastrointest Oncol. 2012 Sep;3(3):209-25. doi: 10.3978/j.issn.2078-6891.2012.024.

6.

Evaluation of total hip arthroplasty devices using a total joint replacement registry.

Paxton EW, Ake CF, Inacio MC, Khatod M, Marinac-Dabic D, Sedrakyan A.

Pharmacoepidemiol Drug Saf. 2012 May;21 Suppl 2:53-9. doi: 10.1002/pds.3228.

PMID:
22552980
7.

Demographically corrected norms for African Americans and Caucasians on the Hopkins Verbal Learning Test-Revised, Brief Visuospatial Memory Test-Revised, Stroop Color and Word Test, and Wisconsin Card Sorting Test 64-Card Version.

Norman MA, Moore DJ, Taylor M, Franklin D Jr, Cysique L, Ake C, Lazarretto D, Vaida F, Heaton RK; HNRC Group.

J Clin Exp Neuropsychol. 2011 Aug;33(7):793-804. doi: 10.1080/13803395.2011.559157. Epub 2011 Jun 24.

8.

Leveraging electronic medical records for surveillance of surgical site infection in a total joint replacement population.

Inacio MC, Paxton EW, Chen Y, Harris J, Eck E, Barnes S, Namba RS, Ake CF.

Infect Control Hosp Epidemiol. 2011 Apr;32(4):351-9. doi: 10.1086/658942.

PMID:
21460486
9.

Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in rural China.

Heaton RK, Cysique LA, Jin H, Shi C, Yu X, Letendre S, Franklin DR Jr, Ake C, Vigil O, Atkinson JH, Marcotte TD, Grant I, Wu Z; HNRC group.

J Neurovirol. 2010 Mar;16(2):185-8. doi: 10.3109/13550284.2010.481820. No abstract available.

10.

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study.

Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Rivera-Mindt M, Vigil OR, Taylor MJ, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I; CHARTER Group.

Neurology. 2010 Dec 7;75(23):2087-96. doi: 10.1212/WNL.0b013e318200d727.

11.

Implications of hepatitis C virus infection for behavioral symptoms and activities of daily living.

Posada C, Moore DJ, Woods SP, Vigil O, Ake C, Perry W, Hassanein TI, Letendre SL, Grant I; HIV Neurobehavioral Research Center Group.

J Clin Exp Neuropsychol. 2010 Jul;32(6):637-44. doi: 10.1080/13803390903418900.

12.

Incidence and nature of cognitive decline over 1 year among HIV-infected former plasma donors in China.

Cysique LA, Letendre SL, Ake C, Jin H, Franklin DR, Gupta S, Shi C, Yu X, Wu Z, Abramson IS, Grant I, Heaton RK; HIV Neurobehavioral Research Center group.

AIDS. 2010 Apr 24;24(7):983-90. doi: 10.1097/QAD.0b013e32833336c8.

13.

[Tuberculous orchi-epididymitis. Report of 2 cases registered in pneumology at the Chu de Cocody].

Kouassi B, Horo K, Gbazi C, Ngom A, Koffi N, Aoussi RD, Aka N, Aké C, Kakou D, Ahui B, Godé C, Aka-Danguy E, Itchy MV.

Mali Med. 2009;24(3):68-70. French. No abstract available.

PMID:
20093211
14.

Alteration of Methamphetamine-induced stereotypic behaviour in transgenic mice expressing HIV-1 envelope protein gp120.

Roberts AJ, Maung R, Sejbuk NE, Ake C, Kaul M.

J Neurosci Methods. 2010 Feb 15;186(2):222-5. doi: 10.1016/j.jneumeth.2009.11.007. Epub 2009 Nov 13.

15.

[Remarkable evolution of hepatic, pleural and pulmonary amoebiasis: a case report].

Horo K, N'gom A, Aké C, Kouassi BA, Godé VC, Ahui BJ, Fotso S, Ouattara K, Kouassi B, Aka-Danguy E.

Rev Mal Respir. 2009 May;26(5):547-51. French.

PMID:
19543174
16.

Psychiatric context of acute/early HIV infection. The NIMH Multisite Acute HIV Infection Study: IV.

Atkinson JH, Higgins JA, Vigil O, Dubrow R, Remien RH, Steward WT, Casey CY, Sikkema KJ, Correale J, Ake C, McCutchan JA, Kerndt PR, Morin SF, Grant I.

AIDS Behav. 2009 Dec;13(6):1061-7. doi: 10.1007/s10461-009-9585-3. Epub 2009 Jun 11.

17.

Negative mood and sexual behavior among non-monogamous men who have sex with men in the context of methamphetamine and HIV.

Bousman CA, Cherner M, Ake C, Letendre S, Atkinson JH, Patterson TL, Grant I, Everall IP; HNRC Group.

J Affect Disord. 2009 Dec;119(1-3):84-91. doi: 10.1016/j.jad.2009.04.006. Epub 2009 May 5.

18.

Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy.

Ellis RJ, Marquie-Beck J, Delaney P, Alexander T, Clifford DB, McArthur JC, Simpson DM, Ake C, Collier AC, Gelman BB, McCutchan JA, Morgello S, Grant I; CHARTER Group.

Ann Neurol. 2008 Nov;64(5):566-72. doi: 10.1002/ana.21484.

19.

Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in rural China.

Heaton RK, Cysique LA, Jin H, Shi C, Yu X, Letendre S, Franklin DR, Ake C, Vigil O, Atkinson JH, Marcotte TD, Grant I, Wu Z; San Diego HIV Neurobehavioral Research Center Group.

J Neurovirol. 2008 Nov;14(6):536-49. doi: 10.1080/13550280802378880. Erratum in: J Neurovirol. 2010 Mar;16(2):185-8.

20.

Long-term survival and serious cardiovascular events in HIV-infected patients treated with highly active antiretroviral therapy.

Bozzette SA, Ake CF, Tam HK, Phippard A, Cohen D, Scharfstein DO, Louis TA.

J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):338-41. doi: 10.1097/QAI.0b013e31815e7251.

PMID:
18176330
21.

Neurobehavioral effects of HIV-1 infection in China and the United States: a pilot study.

Cysique LA, Jin H, Franklin DR Jr, Morgan EE, Shi C, Yu X, Wu Z, Taylor MJ, Marcotte TD, Letendre S, Ake C, Grant I, Heaton RK; HNRC Group.

J Int Neuropsychol Soc. 2007 Sep;13(5):781-90.

22.

Porous organoclay composite for the sorption of polycyclic aromatic hydrocarbons and pentachlorophenol from groundwater.

Ake CL, Wiles MC, Huebner HJ, McDonald TJ, Cosgriff D, Richardson MB, Donnelly KC, Phillips TD.

Chemosphere. 2003 Jun;51(9):835-44.

PMID:
12697173
23.
24.

Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection.

Bozzette SA, Ake CF, Tam HK, Chang SW, Louis TA.

N Engl J Med. 2003 Feb 20;348(8):702-10.

25.

Clean indoor air: advances in California, 1990-1999.

Gilpin EA, Farkas AJ, Emery SL, Ake CF, Pierce JP.

Am J Public Health. 2002 May;92(5):785-91.

26.

Simulated effect of tobacco tax variation on Latino health in California.

Emery S, Ake CF, Navarro AM, Kaplan RM.

Am J Prev Med. 2001 Nov;21(4):278-83. Review.

PMID:
11701298
27.

A novel regulatory gene, Tri10, controls trichothecene toxin production and gene expression.

Tag AG, Garifullina GF, Peplow AW, Ake C Jr, Phillips TD, Hohn TM, Beremand MN.

Appl Environ Microbiol. 2001 Nov;67(11):5294-302.

28.

Initial results of environmental monitoring in the Texas Rio Grande Valley.

Garcia SS, Ake C, Clement B, Huebner HJ, Donnelly KC, Shalat SL.

Environ Int. 2001 Jun;26(7-8):465-74.

PMID:
11485214
29.

Development of porous clay-based composites for the sorption of lead from water.

Ake CL, Mayura K, Huebner H, Bratton GR, Phillips TD.

J Toxicol Environ Health A. 2001 Jul 20;63(6):459-75.

PMID:
11482800
30.

Simulated effect of tobacco tax variation on population health in California.

Kaplan RM, Ake CF, Emery SL, Navarro AM.

Am J Public Health. 2001 Feb;91(2):239-44.

31.

Deamination of fumonisin B(1) and biological assessment of reaction product toxicity.

Lemke SL, Ottinger SE, Ake CL, Mayura K, Phillips TD.

Chem Res Toxicol. 2001 Jan;14(1):11-5.

PMID:
11170503
32.

G-protein signalling mediates differential production of toxic secondary metabolites.

Tag A, Hicks J, Garifullina G, Ake C Jr, Phillips TD, Beremand M, Keller N.

Mol Microbiol. 2000 Nov;38(3):658-65.

33.

Characterizing and identifying "hard-core" smokers: implications for further reducing smoking prevalence.

Emery S, Gilpin EA, Ake C, Farkas AJ, Pierce JP.

Am J Public Health. 2000 Mar;90(3):387-94.

34.

Development and characterization of a carbon-based composite material for reducing patulin levels in apple juice.

Huebner HJ, Mayura K, Pallaroni L, Ake CL, Lemke SL, Herrera P, Phillips TD.

J Food Prot. 2000 Jan;63(1):106-10.

PMID:
10643778

Supplemental Content

Support Center